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Short Communication
Activation of NF-kB/Rel transcription factors in human
primary peripheral blood mononuclear cells by interleukin 7
Figure 1 Activation of NF-kB/Rel by IL-7.
(A) Induction of NF-kB/Rel nuclear complexes by IL-7. T lym-
phocytes were isolated from normal donors’ heparinized blood
by a two-step centrifugation through a Ficoll Hypaque column
(ICN Flow, Opera, Italy) (400 g for 30 min) followed by a 50–
53.5% Percoll (Pharmacia, Uppsala, Sweden) density gradient
(500 g for 30 min). Cells recovered from the pellet were)95%
CD2q and-1% CD33q as determined by immunofluorescence.
T lymphocytes (106/ml) were incubated for 3 h with control medi-
um or 70 ng/ml human recombinant IL-7 (Sanofi-Synthelabo,
Labe´ge, France; specific activity: 3.2=107 U/mg). Cell nuclear
extracts were prepared and incubated with a w32Px-labeled kB
oligonucleotide (59-CAA CGG CAG GGG AAT CTC CCT CTC
CTT-39). The nuclear extract of IL-7-stimulated cells was incu-
bated with the labeled kB oligo in the absence or presence of a
50-fold molar excess of unlabeled AP-1 or kB oligo. DNA/protein
complexes were analyzed by electrophoretic mobility shift assay
(EMSA; Romano et al., 1999). Arrow 1 indicates a non-specific
band, while arrows 2 and 3 indicate specific NF-kB/Rel com-
plexes. Similar results were obtained in experiments with T lym-
phocytes from four different healthy donors. (B) Time course of
NF-kB/Rel activation by IL-7. T lymphocytes (106/ml) were incu-
bated with control medium or IL-7 (70 ng/ml) for 3, 16, 24 or
48 h. NF-kB/Rel nuclear complexes were then analyzed by
EMSA.
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Abstract
Pathways that regulate the activation of NF-kB/Rel tran-
scription factors are known to include signaling through
a number of cytokine receptors. Interleukin 7 (IL-7), pro-
duced by bone marrow and other stromal cells, is a key
factor for differentiation and survival in the lymphoid and
other compartments. We found that human recombinant
IL-7 induced NF-kB/Rel activation, analyzed by electro-
phoretic mobility shift assay (EMSA), in human peripheral
blood T lymphocytes from healthy donors. Induced com-
plexes included p65 and p50 NF-kB/Rel subunits. These
results demonstrate for the first time that IL-7 can partic-
ipate in signaling leading to NF-kB/Rel activation.
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The activity of NF-kB/Rel transcription factors regulates
a number of cellular functions, including cellular prolif-
eration, differentiation and survival (Karin and Lin, 2003;
Kwon et al., 2003). In human leukocytes, NF-kB/Rel-reg-
ulated genes control life/death balance and functional
activation in normal and neoplastic progenitor and dif-
ferentiated cells (Karin and Lin, 2003; Turco et al., 2004).
Among factors that activate NF-kB/Rel in leukocytes,
cytokines, including interleukin (IL)-1, -2, GM-CSF, tumor
necrosis factors and others mediate paracrine signals
originating from the cell environment (Li and Verma,
2002).
IL-7, produced by stromal cells from bone marrow, thy-
mus and other tissues, is a survival factor of key rele-
vance for the differentiation and survival of lymphocytes
(Alpdogan et al., 2003; Jaleco et al., 2003; Khaled and
Durum, 2003; Napolitano et al., 2003). Here we analyzed
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Figure 2 Analysis of NF-kB/Rel complexes activated by IL-7.
(A) Dose-response analysis of NF-kB/Rel activation by IL-7. T
lymphocytes (106/ml) were incubated with control medium or IL-
7 at concentrations of 4, 20 or 100 ng/ml. NF-kB/Rel nuclear
complexes were subsequently analyzed by EMSA. (B) Supershift
analysis of the NF-kB/Rel nuclear complexes induced by IL-7.
T lymphocytes (106/ml) were incubated for 3 h with control medi-
um or IL-7 (70 ng/ml). Cell nuclear extracts were then obtained,
incubated with the w32Px-labeled kB oligo in the absence or the
presence of rabbit pre-immune, anti-p50 or -RelA antibodies,
and analyzed by EMSA. Arrows 1, 2 and 3 indicate a non-spe-
cific band, p50 homodimer and p50/RelA heterodimer, respec-
tively; arrows 4–6 indicate supershifted complexes (for details
see text).
Figure 3 Stimulation of IL-2 receptor a gene expression by IL-
7.
T lymphocytes (106/ml) were incubated for 6 h with control medi-
um, human recombinant IL-7 (70 ng/ml) or phytohemagglutinin-
P (PHA; 1 mg/ml) and phorbol 12-myristate-13-acetate (PMA;
10 ng/ml). Then total cellular RNA was obtained and subjected
to semi-quantitative PCR amplification (Reddy et al., 2001) using
IL-2 receptor a gene-specific primers. GAPDH-specific primers
were used to normalize the signals.
The reaction included an initial cycle of denaturation at 948C for
3 min, followed by 25 cycles of denaturation at 948C for 45 s,
annealing at 608C for 30 s, extension at 728C for 90 s, and a
final extension at 728C for 10 min. The amplified products were
separated by electrophoresis on a 1.2% agarose gel, transferred
onto Hybond-Nq membranes and hybridized with GAPDH- or
IL-2 receptor a gene-specific w32PxdATP-radiolabeled probes.
whether this cytokine could affect NF-kB/Rel activation
in human primary peripheral blood T lymphocytes.
T lymphocytes were isolated from peripheral blood
heparinized samples of four different normal donors and
incubated with control medium or human recombinant
IL-7. We observed a decrease in IkBa levels following cell
stimulation with the interleukin (data not shown). Cell
nuclear extracts were obtained and nuclear NF-kB/Rel
levels were analyzed by electrophoretic mobility shift
assay (EMSA). The results are shown in Figure 1. Com-
pared to nonstimulated cells, IL-7-stimulated cells dis-
played induced levels of NF-kB/Rel nuclear complexes.
Complexes indicated by arrows 2 and 3 were specific,
since their binding to the oligo was not affected by the
presence of a 50-fold molar excess of the unlabeled,
unrelated oligo AP-1, while binding was abolished by
competition with unlabeled kB oligo (Figure 1A). On the
other hand, complexes indicated by arrow 1 were not
abolished by competition with unlabeled kB oligo, and
were therefore attributable to nonspecific binding of the
labeled oligo with an abundant component in the nuclear
extracts (Romano, 1999). To analyze the time course of
NF-kB/Rel activation by IL-7, T lymphocytes were incu-
bated with control medium or IL-7 for 3, 16, 24 or 48 h;
subsequently, NF-kB/Rel nuclear complexes were ana-
lyzed. Induced NF-kB/Rel nuclear levels were detectable
3 h following cell incubation with the interleukin and
declined thereafter (Figure 1B). As shown in Figure 2A,
compared to nonstimulated cells or cells stimulated with
4 ng/ml of IL-7, cells stimulated with 20 or 100 ng/ml of
the interleukin clearly displayed induced levels of NF-kB/
Rel. Next, we analyzed the IL-7-induced complexes (Fig-
ure 2B) with rabbit pre-immune, anti-p50 or -RelA (p65)
antibodies in supershift experiments. Anti-p50 and -RelA
antibodies supershifted the induced complexes, indicat-
ing that these included both p50 and RelA subunits. Spe-
cifically, complexes indicated by arrows 2 and 3 were
supershifted by anti-p50 antibodies, while only the com-
plexes indicated by arrow 3 were supershifted by anti-
RelA antibodies. These results are compatible with the
presence of p50/p50 homodimers in the complexes indi-
cated by band 2 and p50/RelA heterodimers in the com-
plexes indicated by arrow 3. Similar results were
obtained in experiments with T lymphocytes from the
four analyzed donors’ samples.
These findings indicate that NF-kB/Rel factors are acti-
vated by IL-7 in human primary T lymphocytes. Induced
complexes include the transactivating dimer p50/p65,
and indeed we detected the expression of the NF-kB/
Rel-regulated gene, IL-2 receptor a, in IL-7-stimulated T
cells (Figure 3). Based on these results, we suggest that
IL-7 can participate in the regulation of NF-kB/Rel-con-
trolled genes. The molecular events that mediate NF-kB/
Rel activation by IL-7 remain to be detailed. The IL-7
receptor is comprised of two chains, IL-7R a and g; fol-
lowing receptor cross-linking, rapid activation of several
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classes of kinases occurs, including members of the
Janus and Src families and PI3-kinase (Schluns and Lef-
rancois, 2003), a major inducer of Akt, a NF-kB/Rel-acti-
vating kinase (Ozes et al., 1999). The role of these
enzymes in NF-kB/Rel activation by IL-7 remains to be
investigated.
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